Clinical Trials Directory

Trials / Terminated

TerminatedNCT01208493

Dietary Protein in the Very-low-birth-weight Infant

Dietary Protein in the Very-low-birth-weight Infant: Effects of the Level of Dietary Protein on Growth and Feeding Tolerance

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
1 Day – 10 Weeks
Healthy volunteers
Accepted

Summary

In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula. Babies will be fed the assigned formula between the time they achieve full enteral feeds and hospital discharge, for a minimum of 3 weeks. The weight gain (g/d) will be measured and compared between groups. Feeding tolerance, protein-energy status and body composition between the study groups will also be analysed. After discharge, babies will be fed a post-discharge preterm infant formula (PDF) between hospital discharge and 3 m corrected age.

Conditions

Interventions

TypeNameDescription
OTHERpreterm infant formula with high protein levelsminimum 3 weeks feeding until hospital discharge
OTHERpreterm standard infant formulaminimum 3 weeks feeding until hospital discharge

Timeline

Start date
2007-09-01
Primary completion
2011-12-01
Completion
2012-04-01
First posted
2010-09-24
Last updated
2015-03-26

Locations

4 sites across 4 countries: United States, Belgium, France, United Kingdom

Source: ClinicalTrials.gov record NCT01208493. Inclusion in this directory is not an endorsement.